These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3620709)

  • 21. Neuronal efflux of noradrenaline induced by tris or lithium as substitutes for extracellular sodium.
    Bönisch H; Langeloh A
    Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):13-6. PubMed ID: 3016559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The distribution of 3H-(+/-)noradrenaline in rabbit aortic strips after inhibition of the noradrenaline-metabolizing enzymes.
    Henseling M; Eckert E; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(3):205-17. PubMed ID: 940598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of post-ganglionic motor transmission in vas deferens by indirectly acting sympathomimetic drugs.
    Ambache N; Dunk LP; Verney J; Zar MA
    J Physiol; 1972 Dec; 227(2):433-56. PubMed ID: 4345926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The uptake and metabolism of 3H-catecholamines in rat cerebral cortex slices.
    Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Mar; 339(3):293-7. PubMed ID: 2725706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro studies on 6-fluoronoradrenaline at several peripheral sympathetic neuroeffector junctions.
    Shepperson NB; Purcell T; Massingham R; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Aug; 317(1):1-4. PubMed ID: 6269000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.
    Zeitner CJ; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):397-402. PubMed ID: 3821932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The outward transport of axoplasmic noradrenaline induced by a rise of the sodium concentration in the adrenergic nerve endings of the rat vas deferens.
    Stute N; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):124-32. PubMed ID: 6208488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choline+: a substrate of the neuronal noradrenaline carrier in the rat vas deferens.
    Ungell AL; Bönisch H; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):223-7. PubMed ID: 3027585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites.
    Cox SL; Ben A; Story DF; Ziogas J
    Br J Pharmacol; 1995 Mar; 114(5):1057-63. PubMed ID: 7780640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the external concentrations of potassium and sodium on the release of (--)-[3H]noradrenaline from the adrenergic nerves of the rat vas deferens.
    Johns A; Paton DM
    Can J Physiol Pharmacol; 1978 Apr; 56(2):323-6. PubMed ID: 638887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early intraneuronal mobilization and deamination of noradrenaline during global ischemia in the isolated perfused rat heart.
    Carlsson L; Graefe KH; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):508-18. PubMed ID: 3437922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of veratridine on the fluxes of 3H-noradrenaline and 3h-bretylium in the rat vas deferens in vitro.
    Ross SB; Kelder D
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 295(3):183-9. PubMed ID: 1012341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetrodotoxin-sensitive and -resistant effects of veratridine on the noradrenergic neurone of the rat vas deferens.
    Bönisch H; Graefe KH; Keller B
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):264-70. PubMed ID: 6664380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of acetaldehyde on electrical activity during neuroeffector transmission in guinea-pig vas deferens.
    Takeda R; Momose Y; Haji A
    Eur J Pharmacol; 1990 Sep; 186(2-3):197-203. PubMed ID: 1963147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of (+/-)-dobutamine on adrenergic nerve endings.
    Fischer P; Burger A; Graefe KH; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):79-84. PubMed ID: 2786150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The extent of neuronal re-uptake of 3H-noradrenaline in isolated vasa deferentia and atria of the rat.
    Schömig E; Fischer P; Schönfeld CL; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):502-8. PubMed ID: 2559332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dialysate dihydroxyphenylglycol as a window for in situ axoplasmic norepinephrine disposition.
    Yamazaki T; Akiyama T; Kitagwa H; Kawada T; Sunagawa K
    Neurochem Int; 2001 Mar; 38(3):287-92. PubMed ID: 11099788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats.
    Bryan-Lluka LJ; Seers H; Sharpe I
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):536-44. PubMed ID: 8740147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of noradrenaline release by adenosine.
    Wakade AR; Wakade TD
    J Physiol; 1978 Sep; 282():35-49. PubMed ID: 722535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between monoamine oxidase inhibitors and sympathomimetic amines in the rat isolated vas deferens.
    Laporte J; Jané F; Valdecasas FG
    J Pharm Pharmacol; 1968 Feb; 20(2):148-9. PubMed ID: 4384539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.